MASCOT - Post Marketing Registry

CompletedOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Coronary Artery DiseaseAtherosclerosis
Interventions
DEVICE

OrbusNeich COMBO stent

The Combo Stent is composed of the OrbusNeich R stent™, with an abluminal coating of a bioabsorbable polymer matrix formulated with sirolimus for sustained release, and an anti-CD34 antibody cell capture coating on the luminal surface.

Trial Locations (1)

Unknown

Amphia Ziekenhuis, Breda

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

OrbusNeich

INDUSTRY

NCT02183454 - MASCOT - Post Marketing Registry | Biotech Hunter | Biotech Hunter